Drugs / CART-45 cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07451054 | Jul 2026 → Jul 2051 expected | B-cell non-Hodgkin lymphoma, Hodgkins lymphoma, Richter transformation, T-cell non-Hodgkin lymphoma | University of Pennsylvania | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CART-45 cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07451054 ↗ |
| Modality | Cell therapy | “anti-CD45 CAR T cells” NCT07451054 ↗ |